Troutman Pepper Locke’s Joseph Kadlec, Douglas Gray, LuAnne Morrow, and Christopher M. Flanagan recently authored the Reuters Legal News article “Life Sciences Companies May Turn to Spin-Offs to Avoid Sell-Offs” where they discuss spin-offs and split-offs as strategic alternatives for life sciences companies facing market and regulatory pressures.